The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we have a number of randomized control trials that show clear survival benefits in keytruda in specific settings we also have a bunch of settings that have been disappointing and we've had confirmatory randomized trials that don't show benefits so truda might be almost a case-by-case basis what cancer what patient
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
i mean where do the cell-based therapies for immunotherapy fit in or something like checkpoint inhibitors like katruda which i mean boy when those things work they're game changers and when they don't work they don't work yeah i